{"id":"https://openalex.org/W7111908840","doi":null,"title":"Metabolomic signature of circulatory body fluids of individuals with Parkinson\u2019s disease","display_name":"Metabolomic signature of circulatory body fluids of individuals with Parkinson\u2019s disease","publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W7111908840"},"language":"en","primary_location":{"id":"pmh:oai:repositorio.ulisboa.pt:10400.5/99644","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10400.5/99644","pdf_url":null,"source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"master thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/10400.5/99644","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Esteves, Vanessa Sofia da Silva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Esteves, Vanessa Sofia da Silva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.9429000020027161,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.9429000020027161,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.04830000177025795,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11027","display_name":"Metabolism and Genetic Disorders","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":1.0},{"id":"https://openalex.org/keywords/plasma-metabolomics","display_name":"plasma metabolomics","score":0.7450000047683716},{"id":"https://openalex.org/keywords/disease-staging","display_name":"disease staging","score":0.5189999938011169},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.7480000257492065},{"id":"https://openalex.org/keywords/hoehn-and-yahr-stage","display_name":"Hoehn and Yahr stage","score":0.7540000081062317},{"id":"https://openalex.org/keywords/glycerophospholipids","display_name":"glycerophospholipids","score":0.9150000214576721},{"id":"https://openalex.org/keywords/lysophosphatidylcholine","display_name":"lysophosphatidylcholine","score":0.9070000052452087},{"id":"https://openalex.org/keywords/sphingomyelin","display_name":"sphingomyelin","score":0.9300000071525574},{"id":"https://openalex.org/keywords/bile-acids","display_name":"bile acids","score":0.765999972820282},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.6499999761581421},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.8519999980926514},{"id":"https://openalex.org/keywords/gut-brain-axis","display_name":"gut-brain axis","score":0.8330000042915344},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.5720000267028809},{"id":"https://openalex.org/keywords/early-diagnosis","display_name":"early diagnosis","score":0.8240000009536743}],"concepts":[{"id":"https://openalex.org/C21565614","wikidata":"https://www.wikidata.org/wiki/Q12149006","display_name":"Metabolomics","level":2,"score":0.804099977016449},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.6096000075340271},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.603600025177002},{"id":"https://openalex.org/C2776952329","wikidata":"https://www.wikidata.org/wiki/Q420004","display_name":"Glycerophospholipid","level":4,"score":0.5078999996185303},{"id":"https://openalex.org/C61322309","wikidata":"https://www.wikidata.org/wiki/Q423143","display_name":"Sphingomyelin","level":3,"score":0.507099986076355},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4788999855518341},{"id":"https://openalex.org/C58017582","wikidata":"https://www.wikidata.org/wiki/Q6556376","display_name":"Lipidomics","level":2,"score":0.4690000116825104},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.44620001316070557},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.44130000472068787},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.4327000081539154},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.38960000872612},{"id":"https://openalex.org/C135870905","wikidata":"https://www.wikidata.org/wiki/Q903667","display_name":"Metabolome","level":3,"score":0.375},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.3646000027656555},{"id":"https://openalex.org/C192989942","wikidata":"https://www.wikidata.org/wiki/Q68685","display_name":"Metabolic pathway","level":3,"score":0.328000009059906},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.3163999915122986},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.3034000098705292},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29409998655319214},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.2930000126361847},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28610000014305115},{"id":"https://openalex.org/C19038510","wikidata":"https://www.wikidata.org/wiki/Q2005087","display_name":"Polyunsaturated fatty acid","level":3,"score":0.2838999927043915},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27459999918937683},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2745000123977661},{"id":"https://openalex.org/C2780358027","wikidata":"https://www.wikidata.org/wiki/Q407752","display_name":"Neurotoxin","level":2,"score":0.2705000042915344},{"id":"https://openalex.org/C2777896816","wikidata":"https://www.wikidata.org/wiki/Q411945","display_name":"Quinolinic acid","level":4,"score":0.2655999958515167},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2614000141620636},{"id":"https://openalex.org/C2777553358","wikidata":"https://www.wikidata.org/wiki/Q311992","display_name":"Acetylcarnitine","level":3,"score":0.2502000033855438}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:repositorio.ulisboa.pt:10400.5/99644","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10400.5/99644","pdf_url":null,"source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"master thesis"}],"best_oa_location":{"id":"pmh:oai:repositorio.ulisboa.pt:10400.5/99644","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10400.5/99644","pdf_url":null,"source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"master thesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3125488374","https://openalex.org/W7168274472","https://openalex.org/W2794347350","https://openalex.org/W4414014369","https://openalex.org/W4411043308","https://openalex.org/W4391951402","https://openalex.org/W2911579215","https://openalex.org/W6929916136","https://openalex.org/W4391097461","https://openalex.org/W7220416756"],"abstract_inverted_index":{"Parkinson\u2019s":[0],"disease":[1,9,43,161],"(PD)":[2],"is":[3,44],"the":[4,21,69,134,177,189,253,256],"second":[5],"most":[6],"common":[7],"neurodegenerative":[8],"associated":[10],"with":[11,48,125,166,222],"aging,":[12],"characterized":[13],"by":[14,115],"progressive":[15],"loss":[16],"of":[17,61,72,182,191,245,255],"dopaminergic":[18],"neurons":[19],"in":[20,45,201,262],"substantia":[22],"nigra.":[23],"PD":[24,62,87,104,263,280,297],"affects":[25],"about":[26],"10":[27],"million":[28],"people":[29],"globally,":[30],"primarily":[31],"those":[32],"over":[33],"60":[34],"years.":[35],"Current":[36],"diagnostic":[37],"methods":[38,154],"are":[39],"solely":[40],"symptomatic,":[41],"when":[42],"advanced":[46],"stage":[47],"substantial":[49],"neuronal":[50,260],"loss.":[51],"There\u2019s":[52],"an":[53,79],"urgent":[54],"need":[55],"for":[56,86,271,279,287,296],"early":[57,288],"and":[58,67,106,117,145,156,163,169,205,212,226,236,241,248,259,274,290],"accurate":[59],"diagnosis":[60,289],"to":[63,77,82,112,132,188],"enable":[64],"timely":[65],"treatment":[66],"improve":[68],"patient\u2019s":[70],"quality":[71],"life.":[73],"This":[74],"study":[75,268],"aimed":[76],"develop":[78],"analytical":[80],"workflow":[81,137,270],"identify":[83],"potential":[84,277],"biomarkers":[85,278,283],"across":[88],"different":[89],"stages":[90,162],"using":[91],"untargeted":[92],"metabolomics.":[93],"Metabolomic":[94],"profiling":[95],"was":[96,130],"performed":[97],"on":[98],"16":[99],"plasma":[100],"samples":[101],"from":[102],"idiopathic":[103],"patients":[105],"9":[107],"control":[108,164],"samples,":[109],"aged":[110],"47":[111],"83,":[113],"categorized":[114],"Hoehn":[116],"Yahr":[118],"(HY)":[119],"stages.":[120],"Ultra-performance":[121],"liquid":[122],"chromatography":[123],"coupled":[124],"high-resolution":[126],"mass":[127],"spectrometry":[128],"(UPLC-ESI-HR-MS)":[129],"used":[131],"analyze":[133],"samples.":[135],"The":[136,195,243],"optimization":[138],"included":[139],"solvent":[140],"extraction,":[141],"mobile":[142],"phase":[143],"selection,":[144],"chromatographic":[146],"separation,":[147],"enhancing":[148],"metabolite":[149,272],"detection":[150],"sensitivity.":[151],"Multivariate":[152],"statistical":[153],"(PCA":[155],"PLS-DA)":[157],"enabled":[158],"differentiation":[159],"between":[160],"groups,":[165],"high":[167],"R\u00b2":[168],"Q\u00b2":[170],"values":[171],"indicating":[172],"strong":[173],"predictive":[174],"power.":[175],"From":[176],"PLS-DA":[178],"analysis,":[179,275],"400":[180],"variables":[181],"importance":[183],"(VIP)":[184],"were":[185],"identified,":[186],"leading":[187],"annotation":[190],"46":[192],"putative":[193],"biomarkers.":[194],"main":[196],"findings":[197],"revealed":[198],"significant":[199],"alterations":[200],"lipid,":[202],"bile":[203],"acid,":[204],"steroid":[206],"metabolism,":[207],"alongside":[208],"amino":[209],"acid":[210,247],"biosynthesis":[211],"oxidative":[213],"stress.":[214],"Glycerophospholipids":[215],"emerged":[216],"as":[217,231],"a":[218],"highly":[219],"enriched":[220],"pathway,":[221],"increased":[223],"membrane":[224,239],"degradation":[225,240],"remodeling.":[227],"Dysregulated":[228],"metabolites":[229],"such":[230],"lysophosphatidylcholines,":[232],"oxidized":[233],"fatty":[234],"acids,":[235],"sphingomyelins":[237],"indicate":[238],"neuroinflammation.":[242],"presence":[244],"glycodeoxycholic":[246],"reduced":[249],"neuroprotective":[250],"steroids":[251],"highlights":[252],"role":[254],"gut-brain":[257],"axis":[258],"vulnerability":[261],"progression.":[264],"In":[265],"summary,":[266],"this":[267],"provides":[269],"extraction":[273],"identifying":[276],"staging.":[281],"These":[282],"offer":[284],"promising":[285],"targets":[286],"therapeutic":[291],"intervention,":[292],"potentially":[293],"improving":[294],"outcomes":[295],"patients.":[298]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-12-10T00:00:00"}